drugset / Trial / NCT06864143
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19 vaccine in adults ≥18 to \<65 years of age.
Timeline
- Start
- 2025-03-07
- Primary completion
- 2025-10-13
- Completion
- 2025-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-1083 | Messenger RNA (mRNA) | — | — |